✦ LIBER ✦

Optimization of 6,7-Disubstituted-4-(arylamino)quinoline-3-carbonitriles as Orally Active, Irreversible Inhibitors of Human Epidermal Growth Factor Receptor-2 Kinase Activity

✍ Scribed by Tsou, Hwei-Ru; Overbeek-Klumpers, Elsebe G.; Hallett, William A.; Reich, Marvin F.; Floyd, M. Brawner; Johnson, Bernard D.; Michalak, Ronald S.; Nilakantan, Ramaswamy; Discafani, Carolyn; Golas, Jonathan; Rabindran, Sridhar K.; Shen, Ru; Shi, Xiaoqing; Wang, Yu-Fen; Upeslacis, Janis; Wissner, Allan

Book ID: 121188633
Publisher: American Chemical Society
Year: 2005
Tongue: English
Weight: 642 KB
Volume: 48
Category: Article
ISSN: 0022-2623
DOI: 10.1021/jm040159c

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Synthesis and Structure−Activity Relatio

Synthesis and Structure−Activity Relationships of 6,7-Disubstituted 4-Anilinoquinoline-3-carbonitriles. The Design of an Orally Active, Irreversible Inhibitor of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor (EGFR) and the Human Epidermal Growth Factor Receptor-2 (HER-2)

✍ Wissner, Allan; Overbeek, Elsebe; Reich, Marvin F.; Floyd, M. Brawner; Johnson, 📂 Article 📅 2003 🏛 American Chemical Society 🌐 English ⚖ 410 KB

6-Substituted-4-(3-bromophenylamino)quin

6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity

✍ Tsou, Hwei-Ru; Mamuya, Nellie; Johnson, Bernard D.; Reich, Marvin F.; Gruber, Br 📂 Article 📅 2001 🏛 American Chemical Society 🌐 English ⚖ 252 KB

ChemInform Abstract: 6-Substituted-4-(3-

ChemInform Abstract: 6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity.

✍ Hwei-Ru Tsou; et al. et al. 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 28 KB 👁 1 views

Tyrosine Kinase Inhibitors. 13. Structur

Tyrosine Kinase Inhibitors. 13. Structure−Activity Relationships for Soluble 7-Substituted 4-[(3-Bromophenyl)amino]pyrido[4,3- d ]pyrimidines Designed as Inhibitors of the Tyrosine Kinase Activity of the Epidermal Growth Factor Receptor

✍ Thompson, Andrew M.; Murray, Donna K.; Elliott, William L.; Fry, David W.; Nelso 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 262 KB

Irreversible inhibition of epidermal gro

Irreversible inhibition of epidermal growth factor receptor tyrosine kinase with In Vivo activity by N-[4-[(3-bromophenyl)amino]-6-quinazolinyl]-2-butynamide (CL-387,785)

✍ Carolyn M. Discafani; Marion L. Carroll; M.Brawner Floyd Jr.; Irwin J. Hollander 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 358 KB

Tyrosine Kinase Inhibitors. 8. An Unusua

Tyrosine Kinase Inhibitors. 8. An Unusually Steep Structure−Activity Relationship for Analogues of 4-(3-Bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a Potent Inhibitor of the Epidermal Growth Factor Receptor

✍ Bridges, Alexander J.; Zhou, Hairong; Cody, Donna R.; Rewcastle, Gordon W.; McMi 📂 Article 📅 1996 🏛 American Chemical Society 🌐 English ⚖ 302 KB